1.29
price up icon0.00%   0.00
after-market アフターアワーズ: 1.29
loading
前日終値:
$1.29
開ける:
$1.29
24時間の取引高:
211.63K
Relative Volume:
0.18
時価総額:
$79.27M
収益:
$5.03M
当期純損益:
$-185.41M
株価収益率:
-0.4175
EPS:
-3.09
ネットキャッシュフロー:
$-139.79M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+18.35%
6か月 パフォーマンス:
-30.65%
1年 パフォーマンス:
-15.13%
1日の値動き範囲:
Value
$1.27
$1.30
1週間の範囲:
Value
$1.23
$1.325
52週間の値動き範囲:
Value
$1.09
$1.95

Pliant Therapeutics Inc Stock (PLRX) Company Profile

Name
名前
Pliant Therapeutics Inc
Name
セクター
Healthcare (1108)
Name
電話
650-481-6770
Name
住所
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
Name
職員
171
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
PLRX's Discussions on Twitter

Compare PLRX vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PLRX
Pliant Therapeutics Inc
1.29 79.27M 5.03M -185.41M -139.79M -3.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.82 121.40B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
764.93 83.25B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
728.11 46.39B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.51 43.41B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
292.94 33.09B 5.36B 287.73M 924.18M 2.5229

Pliant Therapeutics Inc Stock (PLRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-10 ダウングレード JP Morgan Neutral → Underweight
2025-03-04 再開されました Cantor Fitzgerald Neutral
2025-03-04 ダウングレード Needham Buy → Hold
2025-03-03 ダウングレード Leerink Partners Outperform → Market Perform
2025-03-03 ダウングレード Stifel Buy → Hold
2025-02-10 ダウングレード Canaccord Genuity Buy → Hold
2025-02-10 ダウングレード Citigroup Buy → Neutral
2025-02-10 ダウングレード H.C. Wainwright Buy → Neutral
2025-02-10 ダウングレード JP Morgan Overweight → Neutral
2025-02-10 ダウングレード Oppenheimer Outperform → Perform
2025-02-10 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2025-02-10 ダウングレード Wells Fargo Overweight → Equal Weight
2024-09-09 再開されました Leerink Partners Outperform
2023-12-08 開始されました Wells Fargo Overweight
2023-05-18 開始されました Canaccord Genuity Buy
2023-04-13 開始されました Robert W. Baird Outperform
2022-12-14 開始されました Stifel Buy
2022-12-07 開始されました JP Morgan Overweight
2022-09-01 開始されました Citigroup Buy
2022-07-20 開始されました SVB Leerink Outperform
2022-05-25 開始されました Cantor Fitzgerald Overweight
2021-12-10 開始されました Oppenheimer Outperform
2021-11-24 開始されました RBC Capital Mkts Outperform
2021-11-03 開始されました H.C. Wainwright Buy
2021-04-20 開始されました BTIG Research Buy
2021-04-05 開始されました Citigroup Buy
2020-06-29 開始されました Citigroup Buy
2020-06-29 開始されました Cowen Outperform
2020-06-29 開始されました Needham Buy
2020-06-29 開始されました Piper Sandler Overweight
すべてを表示

Pliant Therapeutics Inc (PLRX) 最新ニュース

pulisher
Mar 03, 2026

Pliant Therapeutics Extends Stockholder Rights Agreement Expiration - TipRanks

Mar 03, 2026
pulisher
Mar 03, 2026

PLRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Pliant Therapeutics (PLRX) extends stockholder rights plan expiration to 2027 - Stock Titan

Mar 03, 2026
pulisher
Mar 01, 2026

Pliant Therapeutics Pivots to Oncology, Highlights Early PLN-101095 Responses at Oppenheimer Conference - Yahoo Finance

Mar 01, 2026
pulisher
Feb 28, 2026

PLRX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Feb 28, 2026
pulisher
Feb 27, 2026

Pliant Therapeutics Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView

Feb 27, 2026
pulisher
Feb 26, 2026

Momentum Shift: Is M I Homes Inc currently under institutional pressure2025 Technical Overview & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn

Feb 26, 2026
pulisher
Feb 25, 2026

PLRX SEC FilingsPliant Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Feb 25, 2026
pulisher
Feb 25, 2026

PLRX: Lead oncology program shows strong early efficacy and safety, with phase Ib starting in Q2 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

PLRX Technical Analysis | PLIANT THERAPEUTICS INC (NASDAQ:PLRX) - ChartMill

Feb 25, 2026
pulisher
Feb 24, 2026

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Receives Average Recommendation of "Reduce" from Analysts - MarketBeat

Feb 24, 2026
pulisher
Feb 24, 2026

Pliant Therapeutics: A Reverse Arbitrage Opportunity Driven By A Poison Pill Expiration - Seeking Alpha

Feb 24, 2026
pulisher
Feb 23, 2026

Pliant Therapeutics to Participate in the Oppenheimer Healthcare Life Science Conference - The Manila Times

Feb 23, 2026
pulisher
Feb 23, 2026

Pliant Therapeutics (PLRX) Expected to Announce Quarterly Earnings on Monday - MarketBeat

Feb 23, 2026
pulisher
Feb 21, 2026

Investment Recap: What is the Moat Score of Pliant Therapeutics IncJuly 2025 Patterns & AI Optimized Trade Strategies - baoquankhu1.vn

Feb 21, 2026
pulisher
Feb 20, 2026

PLRX Should I Buy - Intellectia AI

Feb 20, 2026
pulisher
Feb 19, 2026

Should I hold or sell Pliant Therapeutics Inc. stock in 20252025 Winners & Losers & Short-Term Swing Trade Alerts - mfd.ru

Feb 19, 2026
pulisher
Feb 18, 2026

PLRX Investors Have Opportunity to Join Pliant Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - GuruFocus

Feb 18, 2026
pulisher
Feb 17, 2026

Woodline Partners (PLRX) discloses 3.3% beneficial stake in Pliant - Stock Titan

Feb 17, 2026
pulisher
Feb 14, 2026

PLRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 14, 2026
pulisher
Feb 12, 2026

Chart Watch: What is Pliant Therapeutics Inc.’s book value per shareEarnings Growth Report & Weekly High Potential Stock Alerts - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Short Interest Up 21.0% in January - MarketBeat

Feb 12, 2026
pulisher
Feb 09, 2026

Idiopathic Pulmonary Fibrosis Market: Expanding Revenue - openPR.com

Feb 09, 2026
pulisher
Feb 06, 2026

Aug Analyst Calls: Is GENC on track to beat earningsQuarterly Risk Review & High Conviction Buy Zone Alerts - baoquankhu1.vn

Feb 06, 2026
pulisher
Feb 03, 2026

Portfolio Shifts: Is Pliant Therapeutics Inc. a potential multi baggerJuly 2025 Levels & Fast Gain Swing Trade Alerts - baoquankhu1.vn

Feb 03, 2026
pulisher
Feb 02, 2026

Weekly Earnings: How cyclical is Pliant Therapeutics Incs revenue streamExit Point & Scalable Portfolio Growth Methods - baoquankhu1.vn

Feb 02, 2026
pulisher
Feb 01, 2026

Breakout Zone: Why is Pliant Therapeutics Inc stock going upJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 30, 2026

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Receives Consensus Rating of “Reduce” from Analysts - Defense World

Jan 30, 2026
pulisher
Jan 30, 2026

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Receives Consensus Rating of "Reduce" from Analysts - MarketBeat

Jan 30, 2026
pulisher
Jan 28, 2026

Citadel Advisors LLC Acquires Additional Shares in Pliant Therapeutics Inc - GuruFocus

Jan 28, 2026
pulisher
Jan 28, 2026

Quarterly Earnings: Is Pliant Therapeutics Inc a stock for growth or value investorsJuly 2025 Levels & Free Technical Pattern Based Buy Signals - baoquankhu1.vn

Jan 28, 2026
pulisher
Jan 24, 2026

What’s the beta of Pliant Therapeutics Inc. stockQuarterly Trade Report & Entry Point Confirmation Signals - mfd.ru

Jan 24, 2026
pulisher
Jan 23, 2026

Pliant Therapeutics COO Kuo Minnie Sells $8853 in Shares By Investing.com - Investing.com UK

Jan 23, 2026
pulisher
Jan 22, 2026

Pliant Therapeutics CHRO Cheung sells $9.6k in stock By Investing.com - Investing.com Nigeria

Jan 22, 2026
pulisher
Jan 22, 2026

Bernard Coulie Sells 89,375 Shares of Pliant Therapeutics (NASDAQ:PLRX) Stock - MarketBeat

Jan 22, 2026
pulisher
Jan 22, 2026

Pliant Therapeutics CHRO Cheung sells $9.6k in stock - Investing.com

Jan 22, 2026
pulisher
Jan 22, 2026

Pliant therapeutics CFO Cummings sells $30,722 in stock By Investing.com - Investing.com Canada

Jan 22, 2026
pulisher
Jan 22, 2026

Pliant therapeutics CEO Coulie sells $114k in shares By Investing.com - Investing.com Canada

Jan 22, 2026
pulisher
Jan 22, 2026

Pliant therapeutics CEO Coulie sells $114k in shares - Investing.com

Jan 22, 2026
pulisher
Jan 22, 2026

Pliant Therapeutics COO Kuo Minnie Sells $8853 in Shares - Investing.com

Jan 22, 2026
pulisher
Jan 22, 2026

Aug Analyst Calls: Does Costamare Bulkers Holdings Limited stock reflect fundamentalsJobs Report & Verified Momentum Stock Alerts - baoquankhu1.vn

Jan 22, 2026
pulisher
Jan 19, 2026

Analysis Recap: Is Pliant Therapeutics Inc benefiting from interest rate changesJuly 2025 WrapUp & Weekly High Momentum Picks - baoquankhu1.vn

Jan 19, 2026
pulisher
Jan 17, 2026

Pliant Therapeutics Reports Improved Q3 2025 Results - MSN

Jan 17, 2026
pulisher
Jan 14, 2026

Breakout Move: Whats the beta of Pliant Therapeutics Inc stock2025 Technical Patterns & AI Powered Market Entry Strategies - baoquankhu1.vn

Jan 14, 2026
pulisher
Jan 13, 2026

Risk Check: What sentiment indicators say about Pliant Therapeutics Inc stockEarnings Risk Summary & Reliable Volume Spike Alerts - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 12, 2026

Pliant Therapeutics CFO sells $225,679 in stock - MSN

Jan 12, 2026
pulisher
Jan 10, 2026

Is Pliant Therapeutics Inc. (9PT) stock prepared for digital transitionJuly 2025 Big Picture & Short-Term High Return Strategies - ulpravda.ru

Jan 10, 2026
pulisher
Jan 10, 2026

Retail Trends: Is Pliant Therapeutics Inc. (9PT) stock worth holding before Fed meetingBreakout Watch & Safe Entry Zone Tips - Улправда

Jan 10, 2026
pulisher
Jan 09, 2026

Can Pliant Therapeutics Inc. stock double in next 5 yearsStability vs Neutral Overview & HOKA model picks for your routine - Улправда

Jan 09, 2026
pulisher
Jan 08, 2026

Will Pliant Therapeutics Inc. (9PT) stock beat revenue estimates2025 Biggest Moves & Daily Growth Stock Investment Tips - Улправда

Jan 08, 2026

Pliant Therapeutics Inc (PLRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Pliant Therapeutics Inc (PLRX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Cheung Lily
Chief Human Resource Officer
Jan 20 '26
Sale
1.28
7,534
9,644
44,847
Coulie Bernard
President and CEO
Jan 20 '26
Sale
1.28
89,375
114,400
505,601
Kuo Minnie
Chief Operating Officer
Jan 20 '26
Sale
1.28
6,917
8,854
37,806
$45.68
price down icon 3.69%
$53.83
price down icon 6.87%
$29.72
price up icon 0.68%
$101.95
price down icon 1.78%
$143.57
price down icon 4.21%
biotechnology ONC
$292.94
price down icon 2.03%
大文字化:     |  ボリューム (24 時間):